AzTrials
AzTrials

Obstetric Labor ComplicationsNCT02899481

Role of Intrapartum Ultrasound in Instrumental Delivery

A study testing Transabdominal and transperineal ultrasound in people with Obstetric Labor Complications, run by University of Lisbon at 1 site in Portugal.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Investigators will perform a multicentric randomized controlled trial comparing the effect of transabdominal and transperineal ultrasound in pregnant women in the second stage of labor, in whom it was decided an operative delivery. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Obstetric Labor Complications
What is being tested?
Transabdominal and transperineal ultrasound
Could I receive a placebo?
No, everyone receives an active treatment
How many people
222 participants
Where
1 sitePortugal
Study dates
Sep 2016to Mar 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • pregnant women at term, in labor (≥ 37 weeks of gestation dated by a first trimester ultrasound
  • live singleton pregnancy
  • fetus in a cephalic presentation
  • in the second stage of labor, after the decision to perform an instrumental delivery

Who cannot join

  • fetal malformations
  • emergency situation

Trial locations and contacts

1 site in 1 country.

Portugal1 site
  • Centro Hospitalar Lisboa Norte - Hospital Santa Maria

    Lisbon

Other trials in Portugal

About this study

Official title: Role of Intrapartum Ultrasound in the Efficacy of an Instrumental Delivery

Investigators will perform a multicentric randomized controlled trial comparing the effect of transabdominal and transperineal ultrasound in pregnant women in the second stage of labor, in whom it was decided an operative delivery. Our objective is to evaluate the impact of intrapartal ultrasound measurements, as an auxiliary to clinical evaluation, in the efficacy of an instrumental delivery.

Being tested
Transabdominal and transperineal ultrasound
Medical subject headings
Obstetric Labor Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Transabdominal and transperineal ultrasoundOther

    Transabdominal ultrasound, for determining fetal head position, is performed with the pregnant women in supine position after bladder emptying, with the transducer placed transversely on the suprapubic region of the maternal abdomen. For the sonographic determination of the fetal descent we will perform a transperineal ultrasound achieved by placing the ultrasound transducer on the perineum in a mid sagittal position between the labia below the pubic symphysis.

Study groups in NCT02899481
Study groupRoleWhat they receive
Study groupExperimentalThe study group will be constituted by pregnant women in whom the operative delivery will be preceded by a transabdominal and transperineal ultrasound to evaluate fetal head position and fetal head station, by means of determination of the 'angle of progression'.
Receives: Other: Transabdominal and transperineal ultrasound
Control groupNo interventionThe control group will be constituted by pregnant women in whom the operative delivery will be carried out based solely on clinical criteria, namely transvaginal digital examination.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maternal and neonatal morbidity

    Severe postpartum hemorrhage, perineal trauma, prolonged hospital stay

    Measured: 2 years

  2. Neonatal morbidity

    low 5-minute Apgar score, umbilical artery metabolic acidosis, birth trauma and neonatal intensive care unit admission

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Sep 2016 (estimated)
  2. Study startSep 2016
  3. Primary completionMar 2019
  4. Study completionMar 2019

Why it stopped: Data Safety Monitoring Committee recommended stopping the trial due to futility.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
222 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02899481
Sponsor's protocol ID
CC-157
Status last verified
Jun 2020
First submitted
6 Jul 2016
Last updated
23 Jun 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Transabdominal and transperineal ultrasound in people with Obstetric Labor Complications, run by University of Lisbon at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 23 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Data Safety Monitoring Committee recommended stopping the trial due to futility.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maternal and neonatal morbidity (time frame: 2 years). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jun 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in